Masato Ooka

National Institutes of Health

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

ANDREA ROSARIO BECCARI

Head of EXSCALATE

Dompé farmaceutici SpA

ITALY

View details

Kouji Hirota

University of Tokyo

JAPAN

View details

Vanessa Castelli

ITALY

View details

Oscar Solís

National Institute on Drug Abuse

UNITED STATES

View details

Giovanni Chillemi

Prof.

University of Tuscia

ITALY

View details

Masataka Tsuda

Chief

National Institute of Health Sciences

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Masato Ooka

Research Interests

Explore related searches

Contact this professor

Articles (13)

Profiling of Environmental Mixtures Containing Metals for Their Toxicity Pathways and Mechanism of Action

Use of Tox21 screening data to profile PFAS bioactivities on nuclear receptors, cellular stress pathways, and cytochrome p450 enzymes

Lestaurtinib induces DNA damage that is related to estrogen receptor activation

Liver three-dimensional cellular models for high-throughput chemical testing

The SARS-CoV-2 spike protein binds and modulates estrogen receptors

Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation

Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation

XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA

XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA

Pold4, the fourth subunit of replicative polymerase δ, suppresses gene conversion in the immunoglobulin-variable gene in avian DT40 cells

Pold4, the fourth subunit of replicative polymerase delta, suppresses gene conversion in the immunoglobulin-variable gene in avian DT40 cells

Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition

Profiling the tox21 chemical collection for acetylcholinesterase inhibition

Collaborators (6)

ANDREA ROSARIO BECCARI

Kouji Hirota

Vanessa Castelli

Oscar Solís

Giovanni Chillemi

Masataka Tsuda

Make your next move.